An interventional study of Nutritional and physiotherapy protocol, BIA and Standard of care in Sepsis, Trauma and Respiratory Insufficiency, sponsored by University Hospital Ostrava. Recruiting at 2 sites in Czechia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-18.
Sponsored by University Hospital Ostrava · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Sepsis with a site in Czechia — 4 open to participants now, 5 under way, none of them phase 3. Sepsis · Czechia.
Among the 28 studies in Sepsis with a site in Czechia, this one is the 14th largest by planned enrollment of the 16 interventional ones that give a count, is one of 2 that started in 2021, is one of 5 with no phase, and was the 21st registered.
2,425 studies on the registry are indexed under Sepsis; 543 are open to participants now.
Browse Sepsis studies →4 of the 28 studies in Sepsis with a site in Czechia are open now. Recruiting first, the newest first:
Charles University, Czech Republic · Sites in Czechia
Ages 18+
AstraZeneca · Sites in Czechia, United States, Argentina and 11 more countries
Ages 18–80
Charles University, Czech Republic · Sites in Czechia
Ages 18+ · Healthy volunteers
A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →
Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 2 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 102 across 1,169 interventional studies indexed under Sepsis.
Median enrollment 289 across the 16 interventional studies, 200 across the 11 observational. Of the 21 that completed or were terminated, 5 (24%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 28 have an industry lead sponsor. The 10 most frequent:
University Hospital Ostrava is the lead sponsor of 149 studies on the registry; 51 are open to participants now.
University Hospital Ostrava has 7 studies filed under Sepsis — fewer than ten, so there is no comparison to draw.
1 of the studies in Sepsis with a site in Czechia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07215702AstraZenecaA Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury. | 2027-02-11 |
Add it to your calendar (.ics) → With an account.
Among the 28 studies in Sepsis with a site in Czechia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of the study is to monitor and evaluate changes in body composition, with a special emphasis on muscle mass, in the context of polyneuromyopathy of critically-ill patients at ICU, on artificial ventilation (duration of artificial ventilation at least 7 days), and subsequent comparison with the patient's condition in 12 weeks, as a part of Post-Intensive Care Syndrome (PICS) monitoring. The effect of the package (nutritional recommendations + physiotherapy protocol vs. standard of care) will be evaluated.
Intensive medicine keeps pushing its borders, and enables survival of critical illnesses, including the substitution of organ functions in patients with multiple organ dysfunction (MODS). Despite the improvements in short-term outcomes, the long-term prognosis and quality of life (long-term outcomes) in patients, who survived a critical condition at ICU, remain unfavorable. The long-term consequences may persist for months or even years.
Post-intensive care syndrome (PICS) represents a significantly limiting impairment in three areas: physical (polyneuromyopathy of critically-ill patients), cognitive (delirium), and mental (development of depressions and PTSD - post-traumatic stress disorder). It is especially the rapid deterioration of muscles caused with the catabolic effect of the illness itself during accentuated proteolysis, very negatively affects the muscle strength, inability to discontinue artificial ventilation in the patient, increase of infections, and prolongation of the ICU stay. It often results in the inability to discharge the patient into home care. Polyneuromyopathy affects up to 40% of critically-ill patients; at the greatest risk are especially patients in a serious catabolic state, with activated systemic inflammatory response, with microvascular ischemia, on corticosteroids, immobilized, and on long-term artificial ventilation. The prevention is difficult, as well as monitoring of the lean body mass (LBM), especially in the muscle mass of critically ill patients, who are further affected with changes in hydration and fluid leak.
BIA - bioelectric impedance is a non-invasive technique, which is able, on the basis of impedance, to evaluate body composition (muscles, fat, total body fluid), determine hydration (ratio of extracellular and intracellular fluid, fluid retention); another prognostic marker is also the phase angle. It helps to evaluate markers of nutrition, basal energetic metabolism.
The BIS Multiscan 5000 device measures 50 frequencies, which are used to create a Cole Plot, using a mathematical model. It enables obtaining data from bed-ridden critically-ill patients, using tetrapolar bioelectric impedance.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Study subjects randomized into this study arm will be indicated for nutritional and physiotherapy protocol, based upon the obtained results of the measurements, using bioimpedance analysis.
Other: Nutritional and physiotherapy protocol, BIA
Study subjects randomized into this study arm will be provided the current standard of care.
Other: Standard of care
Study subjects will be treated using the nutritional and physiotherapy protocol, based upon the results of measurements, using bioimpedance analysis.
Study subjects will receive the current standard of care.
Body composition
Body composition will be studied using bioimpedance analysis - comparison of skeletal muscle mass, fats, body fluids
Time frame: 12 weeks
Changes in the albumin level
Changes in the albumin level will be observed (in grams/Litre)
Time frame: 12 weeks
Changes in the prealbumin level
Changes in the prealbumin level will be observed (in milligrams/Litre)
Time frame: 12 weeks
Changes in the C-reactive protein (CRP) level
Changes in the C-reactive protein (CRP) level will be observed (in milligrams/Litre)
Time frame: 12 weeks
Changes in the presepsin level
Changes in the presepsin level will be observed (in picograms/millilitre)
Time frame: 12 weeks
Comparison of muscle functions
Comparison of muscle functions will be performed using dynamometry.
Time frame: 12 weeks
Functional limitations - time up and go test (TUG)
Functional limitations will be assessed with TUG (time up and go test) (in seconds)
Time frame: 12 weeks
Functional limitations - spirometry - forced vital capacity (FCV)
Functional limitations will be assessed with spirometry - forced vital capacity (FCV) (volume)
Time frame: 12 weeks
Functional limitations - spirometry - forced expiratory velocity (FEV1)
Functional limitations will be assessed with spirometry - forced expiratory velocity in one second (FEV1) (velocity)
Time frame: 12 weeks
Cognitive state
Cognitive state of study subjects will be assessed with the presence of post-traumatic stress disorder (PTSD)
Time frame: 12 weeks
Plan to share: No — There is no plan to make individual participant data available to other researchers.
No publications or documents are linked to this record.
Started Mar 2021 (actual). Primary completion is estimated for Feb 2024, 35 months after the start.
Of 303 non-industry interventional studies with no phase under Sepsis, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 35 months is above that.
Counting every sponsor, half of 326 studies reached it within 22 months; a quarter within 11 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.